Visual and Refractive Outcomes Following Stream Light Photorefractive Keratectomy (55μm Epithelial Removal) Versus Conventional Photorefractive Keratectomy

NCT ID: NCT07203976

Last Updated: 2025-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-03

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Photorefractive keratectomy (PRK) is a well-established corneal refractive surgery that involves epithelial removal followed by stromal ablation to correct myopia, hyperopia, and astigmatism. The method of epithelial removal in PRK significantly impacts healing, pain levels, and visual outcomes.

Trans-epithelial PRK (StreamLight) performed on the EX500 excimer laser platform removes the epithelium and reshapes the corneal stroma in a single laser-guided step, potentially reducing tissue manipulation and enhancing epithelial healing. In contrast, manual epithelial removal PRK involves mechanical debridement, with epithelial removal depth being manually controlled. The variability of epithelial thickness in StreamLight PRK may influence visual outcomes, whereas in manual PRK, a fixed epithelial removal depth of 55 microns provides a standardized approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aimed to compare the visual and refractive outcomes of StreamLight PRK versus manual PRK with fixed epithelial removal.

Type of the study: Retrospective cross-sectional study

* Study Setting: Alforsan Eye Centre
* Study subjects:

a. Inclusion criteria:
* Patients aged 18-40 years.
* Myopia up to -6.00 D and astigmatism up to -3.00 D.
* Stable refraction for at least one year.
* No history of ocular surgery or corneal pathology. b. Exclusion criteria:
* Presence of keratoconus or suspected corneal ectasia.
* Severe dry eye disease or significant ocular surface disease.
* History of autoimmune disease or systemic conditions affecting wound healing.
* Prior herpetic eye disease. c. Sample Size Calculation: A sample size calculation will be performed to ensure adequate statistical power. Anticipated enrollment: \[e.g., 50 eyes per group\] based on previous PRK outcome studies (Marshall et al., 2018).
* Study tools (in detail, e.g., lab methods, instruments,steps, chemicals, …):

* Alcon Wavelight EX500 excimer laser (Alcon Laboratories, Fort Worth, TX, USA)
* Wavelight Oculyzer II Am Wolfsmantel 5, Erlangen, Germany
* Autorefractor KR-8900 (Topcon, Tokyo, Japan)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Photorefractive Keratectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients aged 18-40 years, myopia up to -6.00 D and astigmatism up to -3.00 D and Stable refraction

The visual and refractive outcomes of Stream Light Photorefractive keratectomy with fixed epithelial removal.

No interventions assigned to this group

Patients aged 18-40 years, myopia up to -6.00 D and astigmatism up to -3.00 D and Stable refraction

The visual and refractive outcomes of manual Photorefractive keratectomy with fixed epithelial removal.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18-40 years.
* Myopia up to -6.00 D and astigmatism up to -3.00 D.
* Stable refraction for at least one year.
* No history of ocular surgery or corneal pathology.

Exclusion Criteria

* Presence of keratoconus or suspected corneal ectasia.
* Severe dry eye disease or significant ocular surface disease.
* History of autoimmune disease or systemic conditions affecting wound healing.
* Prior herpetic eye disease.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Menatallah Gamal Saleh

lecturer of ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine, Assiut

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

3. Marshall, J., Trokel, S. L., Rothery, S., & Krueger, R. R. (2018). Refractive corneal surgery: The role of epithelial healing and biomechanics. Cornea, 37(7), 853-860.

Reference Type BACKGROUND

Fantes FE, Hanna KD, Waring GO 3rd, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990 May;108(5):665-75. doi: 10.1001/archopht.1990.01070070051034.

Reference Type BACKGROUND
PMID: 2334323 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04-2025-300627

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.